company background image

Hanger NYSE:HNGR Stock Report

Last Price


Market Cap







10 Aug, 2022


Company Financials +
HNGR fundamental analysis
Snowflake Score
Future Growth2/6
Past Performance4/6
Financial Health2/6

HNGR Stock Overview

Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States.

Hanger Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hanger
Historical stock prices
Current Share PriceUS$18.56
52 Week HighUS$23.98
52 Week LowUS$13.42
1 Month Change30.43%
3 Month Change25.75%
1 Year Change-16.73%
3 Year Change-5.60%
5 Year Change63.81%
Change since IPO280.72%

Recent News & Updates

Shareholder Returns

HNGRUS HealthcareUS Market

Return vs Industry: HNGR underperformed the US Healthcare industry which returned 14.3% over the past year.

Return vs Market: HNGR underperformed the US Market which returned -13.5% over the past year.

Price Volatility

Is HNGR's price volatile compared to industry and market?
HNGR volatility
HNGR Average Weekly Movement8.6%
Healthcare Industry Average Movement8.9%
Market Average Movement7.9%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.2%

Stable Share Price: HNGR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: HNGR's weekly volatility (9%) has been stable over the past year.

About the Company

18615,200Vinit Asar

Hanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. It operates in two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and offers payor network contracting services to other O&P providers.

Hanger Fundamentals Summary

How do Hanger's earnings and revenue compare to its market cap?
HNGR fundamental statistics
Market CapUS$726.13m
Earnings (TTM)US$37.29m
Revenue (TTM)US$1.18b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HNGR income statement (TTM)
Cost of RevenueUS$796.67m
Gross ProfitUS$378.85m
Other ExpensesUS$341.55m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)0.95
Gross Margin32.23%
Net Profit Margin3.17%
Debt/Equity Ratio381.4%

How did HNGR perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.


Is HNGR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HNGR?

Other financial metrics that can be useful for relative valuation.

HNGR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.1x
Enterprise Value/EBITDA13x
PEG Ratio1.3x

Price to Earnings Ratio vs Peers

How does HNGR's PE Ratio compare to its peers?

HNGR PE Ratio vs Peers
The above table shows the PE ratio for HNGR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average-8.6x
NHC National HealthCare
TOI Oncology Institute
USPH U.S. Physical Therapy
PNTG Pennant Group
HNGR Hanger

Price-To-Earnings vs Peers: HNGR is expensive based on its Price-To-Earnings Ratio (19.5x) compared to the peer average (-8.6x).

Price to Earnings Ratio vs Industry

How does HNGR's PE Ratio compare vs other companies in the US Healthcare Industry?

Price-To-Earnings vs Industry: HNGR is good value based on its Price-To-Earnings Ratio (19.5x) compared to the US Healthcare industry average (19.6x)

Price to Earnings Ratio vs Fair Ratio

What is HNGR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HNGR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.5x
Fair PE Ratio25.6x

Price-To-Earnings vs Fair Ratio: HNGR is good value based on its Price-To-Earnings Ratio (19.5x) compared to the estimated Fair Price-To-Earnings Ratio (25.6x).

Share Price vs Fair Value

What is the Fair Price of HNGR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: HNGR ($18.56) is trading above our estimate of fair value ($17.03)

Significantly Below Fair Value: HNGR is trading above our estimate of fair value.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Hanger forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score


Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HNGR's forecast earnings growth (15.3% per year) is above the savings rate (1.9%).

Earnings vs Market: HNGR's earnings (15.3% per year) are forecast to grow faster than the US market (14.6% per year).

High Growth Earnings: HNGR's earnings are forecast to grow, but not significantly.

Revenue vs Market: HNGR's revenue (4.7% per year) is forecast to grow slower than the US market (7.9% per year).

High Growth Revenue: HNGR's revenue (4.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if HNGR's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Past Performance

How has Hanger performed over the past 5 years?

Past Performance Score


Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: HNGR has high quality earnings.

Growing Profit Margin: HNGR's current net profit margins (3.2%) are higher than last year (2.8%).

Past Earnings Growth Analysis

Earnings Trend: HNGR has become profitable over the past 5 years, growing earnings by 73.5% per year.

Accelerating Growth: HNGR's earnings growth over the past year (25.5%) is below its 5-year average (73.5% per year).

Earnings vs Industry: HNGR earnings growth over the past year (25.5%) exceeded the Healthcare industry 10.9%.

Return on Equity

High ROE: Whilst HNGR's Return on Equity (29.78%) is high, this metric is skewed due to their high level of debt.

Discover strong past performing companies

Financial Health

How is Hanger's financial position?

Financial Health Score


Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: HNGR's short term assets ($282.9M) exceed its short term liabilities ($230.6M).

Long Term Liabilities: HNGR's short term assets ($282.9M) do not cover its long term liabilities ($611.1M).

Debt to Equity History and Analysis

Debt Level: HNGR's net debt to equity ratio (361.9%) is considered high.

Reducing Debt: HNGR's debt to equity ratio has reduced from 2453.5% to 381.4% over the past 5 years.

Debt Coverage: HNGR's debt is not well covered by operating cash flow (16%).

Interest Coverage: HNGR's interest payments on its debt are not well covered by EBIT (2.4x coverage).

Balance Sheet

Discover healthy companies


What is Hanger current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate HNGR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HNGR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HNGR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HNGR's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as HNGR has not reported any payouts.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Vinit Asar (56 yo)





Mr. Vinit K. Asar has been the Chief Executive Officer and President of Hanger Orthopedic Group Inc. (known as Hanger, Inc.) since May 21, 2012 and September 12, 2011 respectively. Mr. Asar serves as Direc...

CEO Compensation Analysis

Compensation vs Market: Vinit's total compensation ($USD4.61M) is about average for companies of similar size in the US market ($USD3.93M).

Compensation vs Earnings: Vinit's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: HNGR's management team is seasoned and experienced (6.2 years average tenure).

Board Members

Experienced Board: HNGR's board of directors are considered experienced (7.6 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Hanger, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Hanger, Inc.
  • Ticker: HNGR
  • Exchange: NYSE
  • Founded: 1861
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: US$726.128m
  • Shares outstanding: 39.12m
  • Website:

Number of Employees


  • Hanger, Inc.
  • 10910 Domain Drive
  • Suite 300
  • Austin
  • Texas
  • 78758-7807
  • United States


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/10 00:00
End of Day Share Price2022/08/10 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.